Key Drivers
- Margin Recovery
- Cash Generation
- Leverage Pressure
AIAI Summary
FTRE has clearly moved from “broken story” to “early turnaround” after four straight quarters of execution, better-than-expected results, raised guidance, and positive free cash flow, but the stock remains a tactical recovery trade—not a durable rerating candidate—until it proves several more quarters of sustained margin/cash improvement that materially reduce the $1.12B debt, interest burden, and legal overhang.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Recovery
- •Cash Generation
- •Leverage Pressure
FTRE's recent margin and cash-flow improvement is encouraging, but heavy leverage, thin liquidity, and near-bare interest coverage mean the recovery is not yet financially secure.
Price Behavior
Key Price Behavior Insights:
- •Rally Reversal
- •Support Holding
- •Downside Risk
Over the last month, FTRE reversed from a strong rally into a near-term downtrend, with buyers defending $17.4–$17.9, but a break below $17.4 would weaken the setup while a move back above $18.5 would improve it.
Spiked to $20.70 before falling to $17.41, showing sharp volatility and fading momentum
Sentiment & News
Key News Insights:
- •Earnings beat
- •Raised guidance
- •Legal overhang
Fortrea's Q2 earnings beat, raised guidance, and stronger trading momentum improved sentiment, but an active securities-fraud investigation keeps a legal overhang on the stock.
The news is mildly bullish overall on stronger fundamentals and valuation support, but legal risk may keep shares volatile
Similar Companies in Healthcare
Other companies in the same sector with AI ratings